These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23353744)

  • 1. Design, synthesis and anticancer properties of 5-arylbenzoxepins as conformationally restricted isocombretastatin A-4 analogs.
    Rasolofonjatovo E; Provot O; Hamze A; Rodrigo J; Bignon J; Wdzieczak-Bakala J; Lenoir C; Desravines D; Dubois J; Brion JD; Alami M
    Eur J Med Chem; 2013 Apr; 62():28-39. PubMed ID: 23353744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lead identification of conformationally restricted benzoxepin type combretastatin analogs: synthesis, antiproliferative activity, and tubulin effects.
    Barrett I; Carr M; O'Boyle N; Greene LM; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ
    J Enzyme Inhib Med Chem; 2010 Apr; 25(2):180-94. PubMed ID: 20222762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, biological evaluation, and structure-activity relationships of tri- and tetrasubstituted olefins related to isocombretastatin A-4 as new tubulin inhibitors.
    Aziz J; Brachet E; Hamze A; Peyrat JF; Bernadat G; Morvan E; Bignon J; Wdzieczak-Bakala J; Desravines D; Dubois J; Tueni M; Yassine A; Brion JD; Alami M
    Org Biomol Chem; 2013 Jan; 11(3):430-42. PubMed ID: 23047722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid synthesis of 4-arylchromenes from ortho-substituted alkynols: A versatile access to restricted isocombretastatin A-4 analogues as antitumor agents.
    Renko D; Provot O; Rasolofonjatovo E; Bignon J; Rodrigo J; Dubois J; Brion JD; Hamze A; Alami M
    Eur J Med Chem; 2015 Jan; 90():834-44. PubMed ID: 25528337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of azaisoerianin derivatives as potential antitumors agents.
    Soussi MA; Provot O; Bernadat G; Bignon J; Wdzieczak-Bakala J; Desravines D; Dubois J; Brion JD; Messaoudi S; Alami M
    Eur J Med Chem; 2014 May; 78():178-89. PubMed ID: 24681982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fluorine scan of a tubulin polymerization inhibitor isocombretastatin A-4: Design, synthesis, molecular modelling, and biological evaluation.
    Naret T; Bignon J; Bernadat G; Benchekroun M; Levaique H; Lenoir C; Dubois J; Pruvost A; Saller F; Borgel D; Manoury B; Leblais V; Darrigrand R; Apcher S; Brion JD; Schmitt E; Leroux FR; Alami M; Hamze A
    Eur J Med Chem; 2018 Jan; 143():473-490. PubMed ID: 29202409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lead identification of conformationally restricted β-lactam type combretastatin analogues: synthesis, antiproliferative activity and tubulin targeting effects.
    Carr M; Greene LM; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ
    Eur J Med Chem; 2010 Dec; 45(12):5752-66. PubMed ID: 20933304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antitumor activity of benzils related to combretastatin A-4.
    Mousset C; Giraud A; Provot O; Hamze A; Bignon J; Liu JM; Thoret S; Dubois J; Brion JD; Alami M
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3266-71. PubMed ID: 18477509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-(3,4,5-Trimethoxyphenylselenyl)-1H-indoles and their selenoxides as combretastatin A-4 analogs: microwave-assisted synthesis and biological evaluation.
    Wen Z; Xu J; Wang Z; Qi H; Xu Q; Bai Z; Zhang Q; Bao K; Wu Y; Zhang W
    Eur J Med Chem; 2015 Jan; 90():184-94. PubMed ID: 25461319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of biaryl aryl stilbenes/ethylenes as antimicrotubule agents.
    Kumar AS; Reddy MA; Jain N; Kishor C; Murthy TR; Ramesh D; Supriya B; Addlagatta A; Kalivendi SV; Sreedhar B
    Eur J Med Chem; 2013 Feb; 60():305-24. PubMed ID: 23313639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The vascular targeting agent combretastatin-A4 and a novel cis-Restricted {beta}-Lactam Analogue, CA-432, induce apoptosis in human chronic myeloid leukemia cells and ex vivo patient samples including those displaying multidrug resistance.
    Greene LM; Nathwani SM; Bright SA; Fayne D; Croke A; Gagliardi M; McElligott AM; O'Connor L; Carr M; Keely NO; O'Boyle NM; Carroll P; Sarkadi B; Conneally E; Lloyd DG; Lawler M; Meegan MJ; Zisterer DM
    J Pharmacol Exp Ther; 2010 Nov; 335(2):302-13. PubMed ID: 20699436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and activity of Combretastatin A-4 analogues: 1,2,3-thiadiazoles as potent antitumor agents.
    Wu M; Sun Q; Yang C; Chen D; Ding J; Chen Y; Lin L; Xie Y
    Bioorg Med Chem Lett; 2007 Feb; 17(4):869-73. PubMed ID: 17174089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity-relationship studies of conformationally restricted analogs of combretastatin A-4 derived from SU5416.
    Pandit B; Sun Y; Chen P; Sackett DL; Hu Z; Rich W; Li C; Lewis A; Schaefer K; Li PK
    Bioorg Med Chem; 2006 Oct; 14(19):6492-501. PubMed ID: 16860559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic bridged analogs of isoCA-4: Design, synthesis and biological evaluation.
    Pecnard S; Provot O; Levaique H; Bignon J; Askenatzis L; Saller F; Borgel D; Michallet S; Laisne MC; Lafanechère L; Alami M; Hamze A
    Eur J Med Chem; 2021 Jan; 209():112873. PubMed ID: 33038796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of novel 3,4-diaryl-1,2,5-selenadiazol analogues of combretastatin A-4.
    Guan Q; Yang F; Guo D; Xu J; Jiang M; Liu C; Bao K; Wu Y; Zhang W
    Eur J Med Chem; 2014 Nov; 87():1-9. PubMed ID: 25233100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-ring-modified isocombretastatin A-4 analogues endowed with interesting anticancer activities.
    Hamze A; Rasolofonjatovo E; Provot O; Mousset C; Veau D; Rodrigo J; Bignon J; Liu JM; Wdzieczak-Bakala J; Thoret S; Dubois J; Brion JD; Alami M
    ChemMedChem; 2011 Dec; 6(12):2179-91. PubMed ID: 21990101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of thiophene and benzo[b]thiophene analogs of combretastatin A-4 and isocombretastatin A-4: A comparison between the linkage positions of the 3,4,5-trimethoxystyrene unit.
    Do CV; Faouzi A; Barette C; Farce A; Fauvarque MO; Colomb E; Catry L; Berthier-Vergnes O; Haftek M; Barret R; Lomberget T
    Bioorg Med Chem Lett; 2016 Jan; 26(1):174-80. PubMed ID: 26602281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin.
    Odlo K; Hentzen J; dit Chabert JF; Ducki S; Gani OA; Sylte I; Skrede M; Flørenes VA; Hansen TV
    Bioorg Med Chem; 2008 May; 16(9):4829-38. PubMed ID: 18396050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of a series of podophyllotoxins derivatives as a class of potent antitubulin agents.
    Liu Y; Wei D; Zhao Y; Cheng W; Lu Y; Ma Y; Li X; Han C; Wei Y; Cao H; Zhao C
    Bioorg Med Chem; 2012 Nov; 20(21):6285-95. PubMed ID: 23022053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4,5-Diaryl-3-aminopyrazole derivatives as analogs of Combretastatin A-4: synthesis and biological evaluation.
    Liu T; Cui R; Chen J; Zhang J; He Q; Yang B; Hu Y
    Arch Pharm (Weinheim); 2011 May; 344(5):279-86. PubMed ID: 21290430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.